Table 1.
Pre–alvimopan | Alvimopan | P | ||||
---|---|---|---|---|---|---|
N | % | N | % | |||
Gender | Male | 39 | 78% | 27 | 75% | 0.745 |
Female | 11 | 22% | 9 | 25% | ||
Smoker | No | 37 | 77% | 23 | 64% | 0.096 |
Yes | 11 | 23% | 13 | 36% | ||
Neoadjuvant | No | 36 | 73% | 26 | 76% | 0.757 |
Yes | 13 | 27% | 8 | 24% | ||
Mean (SD) | Range | Mean (SD) | Range | P | ||
Age (years) | 64.5 (12.5) | 35–91 | 62.2 (11.5) | 41–82 | 0.335 | |
BMI (kg/m2) | 28.0 (5.1) | 19.9–41.8 | 28.8 (5.7) | 14.8–40.2 | 0.458 |